Asia Pacific Dry Eye Products Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)

No. of Pages: 117    |    Report Code: TIPRE00028846    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Dry Eye Products Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Dry Eye Products Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Dry Eye Products Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Rising Prevalence of Dry Eye
  • 5.1.3 Upsurge in Geriatric Population
5.2 Market Opportunities
  • 5.2.1 Increasing Initiatives for Eye Care Awareness
5.3 Future Trends
  • 5.3.1 Expanding Product Pipeline
5.4 Impact of Drivers and Restraints

6. Asia Pacific Dry Eye Products Market Regional Analysis

6.1 Asia Pacific Dry Eye Products Market Overview
6.2 Asia Pacific Dry Eye Products Market Revenue 2021-2031 (US$ Million)
6.3 Asia Pacific Dry Eye Products Market Forecast Analysis

7. Asia Pacific Dry Eye Products Market Analysis – by Product

7.1 Artificial Tears
  • 7.1.1 Overview
  • 7.1.2 Artificial Tears: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Anti-Inflammatory Drugs
  • 7.2.1 Overview
  • 7.2.2 Anti-Inflammatory Drugs: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Punctal Plugs
  • 7.3.1 Overview
  • 7.3.2 Punctal Plugs: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Secretagogues
  • 7.4.1 Overview
  • 7.4.2 Secretagogues: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Oral Omega Supplements
  • 7.5.1 Overview
  • 7.5.2 Oral Omega Supplements: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Dry Eye Products Market Analysis – by Dosage Form

8.1 Eye Drops
  • 8.1.1 Overview
  • 8.1.2 Eye Drops: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Gel
  • 8.2.1 Overview
  • 8.2.2 Gel: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Capsules
  • 8.3.1 Overview
  • 8.3.2 Capsules: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Tablets
  • 8.4.1 Overview
  • 8.4.2 Tablets: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Dry Eye Products Market Analysis – by Type

9.1 OTC
  • 9.1.1 Overview
  • 9.1.2 Tablets: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Prescription
  • 9.2.1 Overview
  • 9.2.2 Tablets: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Dry Eye Products Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Dry Eye Products Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 10.1.1.1 Asia Pacific Dry Eye Products Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Dry Eye Products Market Breakdown, by Product
    • 10.1.1.1.2 China: Asia Pacific Dry Eye Products Market Breakdown, by Dosage Form
    • 10.1.1.1.3 China: Asia Pacific Dry Eye Products Market Breakdown, by Type
  • 10.1.1.2 India: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Dry Eye Products Market Breakdown, by Product
    • 10.1.1.2.2 India: Asia Pacific Dry Eye Products Market Breakdown, by Dosage Form
    • 10.1.1.2.3 India: Asia Pacific Dry Eye Products Market Breakdown, by Type
  • 10.1.1.3 Japan: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Dry Eye Products Market Breakdown, by Product
    • 10.1.1.3.2 Japan: Asia Pacific Dry Eye Products Market Breakdown, by Dosage Form
    • 10.1.1.3.3 Japan: Asia Pacific Dry Eye Products Market Breakdown, by Type
  • 10.1.1.4 Australia: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Dry Eye Products Market Breakdown, by Product
    • 10.1.1.4.2 Australia: Asia Pacific Dry Eye Products Market Breakdown, by Dosage Form
    • 10.1.1.4.3 Australia: Asia Pacific Dry Eye Products Market Breakdown, by Type
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Dry Eye Products Market Breakdown, by Product
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Dry Eye Products Market Breakdown, by Dosage Form
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Dry Eye Products Market Breakdown, by Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Dry Eye Products Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Santen Pharmaceutical Co Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Johnson & Johnson
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 OASIS Medical
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 URSAPHARM Arzneimittel GmbH
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Rohto Pharmaceutical Co Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 OCuSOFT Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Bausch Health Companies Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 AbbVie Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Prestige Consumer Healthcare Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Farmigea SpA
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Alcon AG
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - A Market

  1. Santen Pharmaceutical Co Ltd
  2. Johnson & Johnson
  3. OASIS Medical
  4. URSAPHARM Arzneimittel GmbH
  5. Rohto Pharmaceutical Co Ltd
  6. OCuSOFT Inc.
  7. Bausch Health Companies Inc
  8. AbbVie Inc
  9. Prestige Consumer Healthcare Inc.
  10. Farmigea SpA
  11. Alcon AG